McIntosh, S.M.; Kerut, C.; Hollenshead, P.P.; Askins, D.H.; Mansourian, K.; Palowsky, Z.R.; Allampalli, V.; Ahmadzadeh, S.; Shekoohi, S.; Kaye, A.D.
Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations. Life 2023, 13, 1601.
https://doi.org/10.3390/life13071601
AMA Style
McIntosh SM, Kerut C, Hollenshead PP, Askins DH, Mansourian K, Palowsky ZR, Allampalli V, Ahmadzadeh S, Shekoohi S, Kaye AD.
Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations. Life. 2023; 13(7):1601.
https://doi.org/10.3390/life13071601
Chicago/Turabian Style
McIntosh, Sydney Moore, Christian Kerut, Payton P. Hollenshead, Dorothy H. Askins, Kasra Mansourian, Zachary R. Palowsky, Varsha Allampalli, Shahab Ahmadzadeh, Sahar Shekoohi, and Alan D. Kaye.
2023. "Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations" Life 13, no. 7: 1601.
https://doi.org/10.3390/life13071601
APA Style
McIntosh, S. M., Kerut, C., Hollenshead, P. P., Askins, D. H., Mansourian, K., Palowsky, Z. R., Allampalli, V., Ahmadzadeh, S., Shekoohi, S., & Kaye, A. D.
(2023). Golimumab for Polyarticular Juvenile Idiopathic Arthritis and Psoriatic Arthritis: Pharmacologic and Clinical Considerations. Life, 13(7), 1601.
https://doi.org/10.3390/life13071601
